Inhibitors of Fibrinolysis in Amniotic Fluid

Summary

Amniotic fluid inhibited the fibrinolytic, amidolytic and esterolytic activity of urokinase. Kinetic studies with AGLMe demonstrated non-competitive inhibition. A major part of the inhibitory activity could be separated from α₁-antitrypsin by ion-exchange chromatography on DEAE-Sephadex A-50. Plasminogen activator prepared from porcine heart was not inhibited by amniotic fluid. Amniotic fluid also inhibited the caseinolytic and amidolytic activities of plasmin.

Key words

Amniotic fluid - Inhibitors of urokinase - Inhibition of fibrinolysis

• References

• 1 Albrechtson OD, Trolle D. A fibrinolytic system in human amniotic fluid. Acta Haematol 1955; 14: 376-382
• 2 Uszynski M, Uszynski-Folejewska R. Plasminogen activator and urokinase inhibitor in myometrium, placenta and amniotic fluid. Am J Obstet Gynecol 1969; 105: 1041-1043
• 3 Aznar J, Hermandez A, Parilla JJ, Estelles A, Gilabert J. Changes in amniotic fluid fibrinolytic inhibitor levels during pregnancy. Thromb Haemostas 1976; 35: 382-385
• 4 Duthie JE, Campbell DM, Ogston D. Inhibition of fibrinolysis by amniotic fluid. In: Davidson JF, Samama MM, Čepelák V, Desnoyers PC. (Eds) Progress in Chemical Fibrinolysis and Thrombolysis. 1979. Vol: IV Churchill Livingstone, Edinburgh: pp 205-208
• 5 Crawford GP M, Ogston D, Douglas AS. The contribution of plasma protease inhibitors to antiplasmin activity in man. Clin Sci 1976; 51: 215-218
• 6 Johnson AJ, Kline DL, Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968. Thromb Diath Haemorrh 1969; 21: 259-272
• 7 Siegelman AM, Carlsen AS, Robertson T. Investigation of serum trypsin and related substances I. The quantitative demonstration of trypsin-like activity in human blood serum by a micromethod. Arch Biochem Biophys 1962; 97: 159-163
• 8 Beattie AG, Ogston D, Bennett NB, Douglas AS. Inhibitors of plasminogen activation in human blood. Br J Haematol 1976; 32: 135-143
• 9 Rickli EE, Zaugg H. Isolation and purification of highly enriched tissue plasminogen activator from pig heart. Thromb Diath Haemorrh 1970; 23: 64-76
• 10 Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochem 1965; 2: 235-238
• 11 Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin reagent. J Biol Chem 1951; 193: 265-278
• 12 Lineweaver J, Burk J. The determination of enzyme dissociation constants. J Chem Soc 1934; 56: 658-665
• 13 Kawano T, Uemura Y. Inhibition of tissue activator by urokinase inhibitor. Thromb Diath Haemorrh 1971; 25: 129-133
• 14 Uszynski M, Abildgaard V. Separation and characterisation of two fibrinolytic inhibitors from human placenta. Thromb Diath Haemorrh 1971; 25: 580-589
• 15 Brakman P, Astrup T. Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand J Clin Lab Invest 1963; 15: 603-609
• 16 Thorsen S. The inhibition of tissue plasminogen activator and urokinase induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects. Scand J Clin Lab Invest 1973; 31: 51-59
• 17 Clemmensen I, Thorsen S, Mullertz S. Purification of a plasminogen activator inhibitor indistinguishable from α₁-antitrypsin and a urokinase inhibitor in pregnancy plasma. Haemostasis 1976; 5: 218-230
• 18 Mackie M, Bennett B, Ogston D. A comparative study of the activators of plasminogen of human origin. In: Davidson JF, Samama MM, Čepelák V, Desnoyers PC. (Eds) In: Progress in Chemical Fibrinolysis and Thrombolysis. 1979. IV: Churchill-Livingstone, Edinburgh: pp 20-24